Taginostat, a new quinolone-based HDAC6 inhibitor, promotes apoptosis of chronic lymphocytic leukemia cells in vitro and in vivo by activating STAT4

Apoptosis · Published 2026-07-01 · DOI 10.1007/s10495-026-02393-0

Authors (18)

Vanessa Tatangelo, Gabriele Carullo, Ludovica Lopresti, Cristina Ulivieri, Simone Brogi, Stefania Butini, Matteo Gatta, Nagaja Capitani, Federica Rungo, Maria Carmela Cavallo, Alessandro Gozzetti, Monica Bocchia, Monica Tozzi, Sara Ciofini, Sandra Gemma, Cosima T Baldari, Giuseppe Campiani, Laura Patrussi

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Tatangelo, V., Carullo, G., Lopresti, L., et al. (2026). Taginostat, a new quinolone-based HDAC6 inhibitor, promotes apoptosis of chronic lymphocytic leukemia cells in vitro and in vivo by activating STAT4. Apoptosis. https://doi.org/10.1007/s10495-026-02393-0

Related articles